Vycor Medical, Inc. (VYCO)
0.0672
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Vycor Medical Shareholders Equity (Quarterly) : -4.251M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.251M |
| March 31, 2026 | -4.229M |
| December 31, 2025 | -4.087M |
| September 30, 2025 | -4.024M |
| June 30, 2025 | -3.867M |
| March 31, 2025 | -3.891M |
| December 31, 2024 | -3.690M |
| September 30, 2024 | -3.683M |
| June 30, 2024 | -3.528M |
| March 31, 2024 | -3.518M |
| December 31, 2023 | -3.326M |
| September 30, 2023 | -3.232M |
| June 30, 2023 | -3.018M |
| March 31, 2023 | -3.096M |
| December 31, 2022 | -2.941M |
| September 30, 2022 | -2.820M |
| June 30, 2022 | -2.599M |
| March 31, 2022 | -2.586M |
| December 31, 2021 | -2.395M |
| September 30, 2021 | -2.260M |
| June 30, 2021 | -2.179M |
| March 31, 2021 | -2.264M |
| December 31, 2020 | -1.981M |
| September 30, 2020 | -1.907M |
| June 30, 2020 | -1.674M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.558M |
| December 31, 2019 | -1.354M |
| September 30, 2019 | -1.267M |
| June 30, 2019 | -1.029M |
| March 31, 2019 | -0.9778M |
| December 31, 2018 | -0.7688M |
| September 30, 2018 | -0.4199M |
| June 30, 2018 | -0.2398M |
| March 31, 2018 | -0.2902M |
| December 31, 2017 | 0.0814M |
| September 30, 2017 | 0.4119M |
| June 30, 2017 | 0.854M |
| March 31, 2017 | 0.7508M |
| December 31, 2016 | -0.0264M |
| September 30, 2016 | 0.3991M |
| June 30, 2016 | 0.6578M |
| March 31, 2016 | 0.8729M |
| December 31, 2015 | 1.146M |
| September 30, 2015 | 1.516M |
| June 30, 2015 | 1.964M |
| March 31, 2015 | 2.357M |
| December 31, 2014 | 2.889M |
| September 30, 2014 | 3.431M |
| June 30, 2014 | 1.487M |
| March 31, 2014 | -0.2473M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.8132M |
| Total Liabilities (Quarterly) | 5.064M |
| Debt to Equity Ratio | -0.2253 |
| Current Ratio | 0.129 |
| Net Debt Paydown Yield | 0.64% |